European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: PYPD) | Delayed: 5.25 +0.12 (2.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.13 | 52 Week High | $ | |||
| Open | $5.14 | 52 Week Low | $ | |||
| Day High | $5.25 | P/E | N/A | |||
| Day Low | $5.11 | EPS | $ | |||
| Volume | 103,889 | |||||
